Emapalumab as bridge to hematopoietic cell transplant for STAT1 gain-of-function mutations
Binni Kunvarjee, Alan Bidgoli, Rebecca Pellett Madan, E.H. Vidal, Devin McAvoy, Kinga Hosszu, Andromachi Scaradavou, Barbara Spitzer, Kevin J. Curran, Maria Cancio, Andrew C. Harris, Richard J. O’Reilly, Andrew L. Kung, Susan E. Prockop, Jaap Jan Boelens, Joseph H. Oved
Topics & Concepts
STAT1Hemophagocytic lymphohistiocytosisHematopoietic stem cell transplantationHaematopoiesisPrimary immunodeficiencyImmunologyTranscription factorImmunodeficiencyCancer researchHematopoietic cellBiologyMedicineTransplantationStem cellInterferonCell biologyImmune systemInternal medicineGeneGeneticsDiseaseAutoimmune and Inflammatory Disorders ResearchImmunodeficiency and Autoimmune DisordersChronic Lymphocytic Leukemia Research